Vivek Mangla, MD
Clinical Cardiac Electrophysiology · Lufkin, TXNPI 1568579233
Payments from drug & device makers
Across 383 payments — averaging $185.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$26K
- Abbott$22K
- Angiodynamics, Inc.$8K
- Medtronic$7K
- Boston Scientific$3K
- Abiomed$1K
- plus $4K from 20 others
Across 6 payments — averaging $1590.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$10K
What the payments were for
- Consulting fees$11,66417%
- Speaking & faculty fees$23,10034%
- Travel & lodging$16,63225%
- Food & beverage$8,46312%
- Education$1980%
- Other$7,67811%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 22 | $25,756 |
| Abbott | 116 | $22,399 |
| Angiodynamics, Inc. | 3 | $7,746 |
| Medtronic(2 entities) | 33 | $6,697 |
| Boston Scientific | 38 | $2,833 |
| Abiomed | 9 | $1,396 |
| Biotronik Inc. | 1 | $716 |
| Cardiovascular Systems Inc. | 6 | $681 |
| Novartis | 34 | $458 |
| Merck | 20 | $403 |
| E.r. Squibb & Sons, L.L.C. | 24 | $375 |
| Johnson & Johnson | 19 | $254 |
| Astellas Pharma US Inc | 3 | $215 |
| Stryker | 4 | $212 |
| Amgen | 11 | $193 |
| Pfizer | 11 | $163 |
| Philips North America LLC | 4 | $113 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $87 |
| W. L. Gore & Associates, Inc. | 2 | $81 |
| Boehringer Ingelheim | 4 | $64 |
| Bard Peripheral Vascular, Inc. | 2 | $45 |
| Sanofi-aventis U.S. LLC | 3 | $42 |
| Biosense Webster, Inc. | 1 | $34 |
| Inari Medical, Inc. | 1 | $34 |
| Amarin Pharma, Inc. | 1 | $15 |
| EKOS Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$25,528
- Auryon Atherectomy Catheter$6,511
- Ensite Cardiac Mapping System$5,400
- AVEIR$4,360
- Confirm Rx$3,900
- Micra$2,971
- Quadra Assura CRT Defibrillator$2,000
- Farapulse$1,764
- TurboHawk$1,465
- Impella$1,203
- Auryon Laser System 100-120 Vac$1,167
- AMPLATZER Occluders$958
- Diamondback Peripheral$593
- CARDIOMEMS$227
- Assurity Pacemaker$200
- Rhythmia Mapping System$174
- AZURE XT DR MRI SURESCAN$122
- VIEWMATE$104
- ENSITE PRECISION$104
How this compares
$71,021 in reported general payments places this provider in the 65th percentile of 233 clinical cardiac electrophysiology providers in Texas.
See all clinical cardiac electrophysiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 275 | $247,645 |
| EntrestoSacubitril/Valsartan | 152 | $127,959 |
| XareltoRivaroxaban | 124 | $118,945 |
| BrilintaTicagrelor | 57 | $30,675 |
| Repatha SureclickEvolocumab | 29 | $22,040 |
| MultaqDronedarone Hcl | 27 | $21,711 |
| JardianceEmpagliflozin | 12 | $10,981 |
| FarxigaDapagliflozin Propanediol | 11 | $10,510 |
| Amiodarone Hcl | 135 | $5,247 |
| Metoprolol Succinate | 330 | $4,578 |
| ClopidogrelClopidogrel Bisulfate | 347 | $3,275 |
| Clonidine | 21 | $1,975 |
| Midodrine Hcl | 16 | $1,530 |
| Metoprolol Tartrate | 193 | $1,525 |
| Losartan Potassium | 178 | $1,485 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $163 | $247,645275 claims |
| NovartisEntresto | $458 | $127,959152 claims |
| Johnson & JohnsonXarelto | $254 | $118,945124 claims |
| Sanofi-aventis U.S. LLCMultaq | $42 | $21,71127 claims |
| Boehringer IngelheimJardiance | $64 | $10,98112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 233 clinical cardiac electrophysiology providers in Texas.
Other clinical cardiac electrophysiology in Lufkin
- Andrea NataleAustin$7.8M
- George ManoukianShenandoah$3.2M
- Rodney HortonAustin$2.5M
- Stanislav WeinerLongview$2.4M
- Michael DelaughterBedford$2.1M
- James DevillePlano$1.5M
- Robert CanbyAustin$1.5M
- Amin Al-AhmadAustin$1.4M
- Theodore TakataFort Worth$1.4M
- Miguel ValderrabanoHouston$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.